) ………………………………………………………………………………………………………………………………………………….… ………………………………………………………………………………………………………………………………………………….… Wish to express an intention to apply for an SEC Account from the SEC Office in the following manners: Not an urgent application (normal case) An urgent application (a seven-day expiry from the SEC
) ………………………………………………………………………………………………………………………………………………….… ………………………………………………………………………………………………………………………………………………….… Wish to express an intention to apply for an SEC Account from the SEC Office in the following manners: Not an urgent application (normal case) An urgent application (a seven-day expiry from the SEC
of July-December 2017 at Baht of 0.04 per share. The total outstanding shares entitled for the dividend is 4,554,643,575 shares and total dividend amount is Baht 182,185,743, the record date for the
of July-December 2017 at Baht of 0.04 per share. The total outstanding shares entitled for the dividend is 4,554,643,575 shares and total dividend amount is Baht 182,185,743, the record date for the
) Nature of relationship The Company holds 70% of the share in the Company’s subsidiary, KT Medical Service Company Limited and the details of connected persons are as follows: Related Person Position
transfer to UE by (a) issuing 70,064,516,130 newly issued preferred shares1, with a par value of Baht 1 per share, at an offering price of Baht 0.031 per share, and 35,032,258,065 units of warrants to
value of THB 5 per share: (1) To accommodate the allocation of 3,425,090,482 newly issued ordinary shares to the existing shareholders pro rata to their shareholdings (Rights Offering), at the par value
. Information contained in this news release is as of the aforementioned release date. For those who wish to see current status of the matter, please go to compliant filed with inquiry officer
Characteristics of Company Directors and Executives date 23 January 2017. Information contained in this news release is as of the aforementioned release date. For those who wish to see current status of the matter
implementing the cross-border equity offering and the issuance of DR, and also covers issuing guidelines to provide guidance for issuers who wish to offer securities, either cross-border equity offering or DR